The primary objective of this study is to confirm the long-term efficacy (remission and maintenance in remission) of current validated treatments. Each patient will be followed during 3 years in this non-interventional trial.
Study Type
OBSERVATIONAL
Enrollment
812
Remission rate (ulcerative colitis) - calculated by UCCS (Ulcerative Colitis Clinical Score)
Time frame: From baseline (inclusion visit) and at 1 year interval after baseline
Remission rate (ulcerative colitis) - calculated by UCCS (Ulcerative Colitis Clinical Score)
Time frame: From baseline (inclusion visit) and at 2 year interval after baseline
Remission rate (ulcerative colitis) - calculated by UCCS (Ulcerative Colitis Clinical Score)
Time frame: From baseline (inclusion visit) and at 3 year interval after baseline
Remission rate (endoscopic) - calculated by UC-DAI (Ulcerative Colitis Disease Activity Index)
Time frame: From baseline (inclusion visit) and at 1 year interval after baseline
Assessing treatment adherence by patient's completion of questionnaire MMAS-8 (Modified Morisky Adherence Scale)
Time frame: From baseline (inclusion visit) and at 1 year interval after baseline
Occurence/number of adverse events
Time frame: From baseline (inclusion visit) to year 3 after baseline
Colonoscopy (if available) - assessing endoscopic activity of the ulcerative colitis
Time frame: From baseline (inclusion visit) to 3 year after baseline
Remission rate (endoscopic) - calculated by UC-DAI (Ulcerative Colitis Disease Activity Index)
Time frame: From baseline (inclusion visit) and at 2 year interval after baseline
Remission rate (endoscopic) - calculated by UC-DAI (Ulcerative Colitis Disease Activity Index)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Centre Hospitalier pays d aix
Aix-en-Provence, France
Investigational site
Amboise, France
Cabinet Médical
Amiens, France
CMAD
Amiens, France
Clinique Saint Joseph
Angers, France
Investigational site
Anglet, France
Cabinet Médical
Arras, France
Hopital Robert Ballanger
Aulnay-sous-Bois, France
Investigational site
Aulnays Sous Bois, France
Polyclinique Ste Marguerite
Auxerre, France
...and 148 more locations
Time frame: From baseline (inclusion visit) and at 3 year interval after baseline
Assessing treatment adherence by patient's completion of questionnaire MMAS-8 (Modified Morisky Adherence Scale)
Time frame: From baseline (inclusion visit) and at 2 year interval after baseline
Assessing treatment adherence by patient's completion of questionnaire MMAS-8 (Modified Morisky Adherence Scale)
Time frame: From baseline (inclusion visit) and at 3 year interval after baseline